1989
DOI: 10.1016/0002-8703(89)90670-4
|View full text |Cite
|
Sign up to set email alerts
|

Ambulatory sudden cardiac death: Mechanisms of production of fatal arrhythmia on the basis of data from 157 cases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

7
273
1
22

Year Published

1991
1991
2018
2018

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 874 publications
(316 citation statements)
references
References 24 publications
7
273
1
22
Order By: Relevance
“…54,55 More recent studies, however, suggest that the incidence of VF or pulseless VT as the first recorded rhythm in out-of-hospital cardiac arrest has declined to <30 % in the past few decades. [56][57][58] Pulseless electrical activity (electromechanical dissociation) and asystole are proportionally more frequent mechanisms than VT/VF.…”
Section: Pathophysiologymentioning
confidence: 99%
“…54,55 More recent studies, however, suggest that the incidence of VF or pulseless VT as the first recorded rhythm in out-of-hospital cardiac arrest has declined to <30 % in the past few decades. [56][57][58] Pulseless electrical activity (electromechanical dissociation) and asystole are proportionally more frequent mechanisms than VT/VF.…”
Section: Pathophysiologymentioning
confidence: 99%
“…2 Ventricular tachycardia (VT) or ventricular fibrillation (VF) is the initiating event in the majority of SCD cases. 3 Ejection fraction (EF) remains the only major criterion to stratify patients for risk of SCD and implantable cardioverter-defibrillator (ICD) implantation, but this strategy alone is insensitive and nonspecific. 4 Genetic susceptibility to SCD in the setting of CAD is supported by several epidemiologic studies demonstrating that a family history of SCD is an independent risk factor for SCD and primary VF.…”
Section: Introductionmentioning
confidence: 99%
“…Ventricular fibrillation (VF) is a terminal cardiac dysrhythmia in humans,1, 2 occurring either as a primary or a secondary event to concomitant cardiac and noncardiac diseases. Currently, there is no cure for VF, with only rudimentary treatment options available; thus, sudden cardiac death from VF remains a major worldwide health problem 3, 4.…”
mentioning
confidence: 99%